D. E. Shaw & Co. Inc. Grows Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

D. E. Shaw & Co. Inc. lifted its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 749.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 221,992 shares of the real estate investment trust's stock after purchasing an additional 195,854 shares during the quarter. D. E. Shaw & Co. Inc. owned 0.09% of Sabra Health Care REIT worth $3,845,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Barclays PLC raised its position in shares of Sabra Health Care REIT by 56.1% during the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock worth $12,624,000 after purchasing an additional 243,895 shares during the period. Bank of New York Mellon Corp raised its position in shares of Sabra Health Care REIT by 13.0% during the fourth quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock worth $69,967,000 after purchasing an additional 463,601 shares during the period. abrdn plc raised its position in shares of Sabra Health Care REIT by 2.9% during the fourth quarter. abrdn plc now owns 900,690 shares of the real estate investment trust's stock worth $15,600,000 after purchasing an additional 25,195 shares during the period. ExodusPoint Capital Management LP grew its holdings in Sabra Health Care REIT by 66.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 917,166 shares of the real estate investment trust's stock worth $15,885,000 after buying an additional 367,777 shares in the last quarter. Finally, Columbus Macro LLC bought a new stake in Sabra Health Care REIT during the fourth quarter worth $5,729,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Truist Financial upped their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Scotiabank upped their price target on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a report on Monday, May 12th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Sabra Health Care REIT currently has an average rating of "Moderate Buy" and a consensus price target of $19.50.

Sabra Health Care REIT Stock Performance

NASDAQ:SBRA traded up $0.35 during trading on Friday, reaching $17.44. The company's stock had a trading volume of 2,710,400 shares, compared to its average volume of 2,205,437. The firm has a market cap of $4.15 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The firm has a 50 day moving average of $17.52 and a 200-day moving average of $17.38. Sabra Health Care REIT, Inc. has a 12 month low of $13.87 and a 12 month high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. The company had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.35 EPS. Research analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Stockholders of record on Friday, May 16th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.88%. Sabra Health Care REIT's payout ratio is 203.39%.

Insider Transactions at Sabra Health Care REIT

In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director now owns 64,725 shares in the company, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.20% of the stock is owned by corporate insiders.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.